Cargando…
S2.1d Incidence of mixed fungal infections in post-COVID-19 outbreak of Mucormycosis
S2.1 UPDATE ON MUCORMYCOSIS, SEPTEMBER 21, 2022, 3:00 PM - 4:30 PM: INTRODUCTION: Post-COVID-19 rhino orbital mucormycosis has emerged as an important life-threatening complication adding to mortality. Fungal infections are a major health challenge, especially in the immunocompromised. Mucormycosi...
Autores principales: | Mohapatra, Subhashree, Tanveer, Nadeem, Gupta, Kanika, Sharma, Sonal, Das, Shukla, Nirmal, Kirti, Singh, Narendra Pal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516026/ http://dx.doi.org/10.1093/mmy/myac072.S2.1d |
Ejemplares similares
-
P430 Correlation of microscopy and culture findings with serum ferritin level for the diagnosis of rhino-orbito-cerebral Mucormycosis during COVID-19 pandemic—a study from tertiary care hospital India
por: Lakshmanan, Jothisri, et al.
Publicado: (2022) -
P374 Fungal coinfection in patients with SARS-CoV-2: Atertiary care hospital study
por: Saini, Vikas, et al.
Publicado: (2022) -
P122 Myeloid-derived suppressor cells as a potential biomarker and therapeutic target in rhino-orbital mucormycosis patients
por: Singh, Praveen, et al.
Publicado: (2022) -
P367 Candida sepsis in neonates a neglected pathogen: study from neonatal intensive care unit tertiary care hospital
por: Nirmal, Kirti, et al.
Publicado: (2022) -
P119 Dysregulated IL-23R and CD25 T cells in post -COVID-19 Rhino-Orbital Mucormycosis patients
por: Rai, Gargi, et al.
Publicado: (2022)